{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:00:55Z","timestamp":1792155655785,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Framework Program 7","award":["FP7-Health 309820"],"award-info":[{"award-number":["FP7-Health 309820"]}]},{"name":"National Institute of Health Grants","award":["R01 HL118440"],"award-info":[{"award-number":["R01 HL118440"]}]},{"name":"National Institute of Health Grants","award":["R01HL125703"],"award-info":[{"award-number":["R01HL125703"]}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","award":["R01 EB009638"],"award-info":[{"award-number":["R01 EB009638"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cDe Drie Lichten\u201d"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jconrel.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,7,9]],"date-time":"2017-07-09T14:16:09Z","timestamp":1499609769000},"page":"47-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis"],"prefix":"10.1016","volume":"262","author":[{"given":"Amr","family":"Alaarg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max L.","family":"Senders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Varela-Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-0629","authenticated-orcid":false,"given":"Carlos","family":"P\u00e9rez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josbert M.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.07.013_bb0005","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0010","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"History of discovery : inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0020","first-page":"709","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","article-title":"Monocytes in atherosclerosis: subsets and functions","volume":"7","author":"Woollard","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0040","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm.3258","article-title":"Local proliferation dominates lesional macrophage accumulation in atherosclerosis","volume":"19","author":"Robbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcmg.2014.10.009","article-title":"Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans","volume":"8","author":"Emami","year":"2015","journal-title":"JACC.Cardiovasc. Imaging"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0075","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0080","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.1208\/aapsj0902015","article-title":"Targeted pharmaceutical nanocarriers for cancer therapy and imaging","volume":"9","author":"Torchilin","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.03.017","article-title":"MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound","author":"Timbie","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0090","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2011.12.014","article-title":"Drug targeting systems for inflammatory disease: one for all, all for one","volume":"161","author":"Crielaard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0095","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2014.05.039","article-title":"Liposomal corticosteroids for the treatment of inflammatory disorders and cancer","volume":"190","author":"Ozbakir","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nmat3780","article-title":"Imaging macrophages with nanoparticles","volume":"13","author":"Weissleder","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0110","first-page":"337","article-title":"Nanomaterials for drug delivery","volume":"80","author":"Hubbell","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0115","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s11095-010-0233-4","article-title":"Polymeric micelles in anticancer therapy: targeting, imaging and triggered release","volume":"27","author":"Oerlemans","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.nantod.2012.08.005","article-title":"Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects","volume":"7","author":"Deng","year":"2012","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/ar200017e","article-title":"Lipoprotein-inspired nanoparticles for cancer theranostics","volume":"44","author":"Ng","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd4279","article-title":"HDL-targeted therapies: progress, failures and future","volume":"13","author":"Kingwell","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2014.06.042","article-title":"Progress of drug-loaded polymeric micelles into clinical studies","volume":"190","author":"Cabral","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2017.01.011","article-title":"Drug delivery research for the future: expanding the nano horizons and beyond","volume":"246","author":"Mitragotri","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0145","article-title":"Cancer nanomedicine: is targeting our target?","volume":"1","author":"Lammers","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0150","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0165","article-title":"Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques","volume":"82","author":"Alaarg","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0170","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.21.1.115","article-title":"Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering","volume":"21","author":"Sparrow","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0180","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0190","first-page":"227","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400223","article-title":"Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation","volume":"1","author":"Tang","year":"2015","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0200","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1021\/acsnano.5b00929","article-title":"Complete regression of xenograft tumors upon targeted delivery of paclitaxel via \u03c0 - \u03c0 stacking stabilized polymeric micelles","volume":"9","author":"Shi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0205","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2967\/jnumed.114.141861","article-title":"A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting","volume":"55","author":"P\u00e9rez-Medina","year":"2014","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1593\/neo.07913","article-title":"Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue","volume":"10","author":"Banciu","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0215","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/nn506750r","article-title":"Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging","volume":"9","author":"Lobatto","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0220","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2967\/jnumed.115.158956","article-title":"Of tumor-associated macrophages with 89Zr-labeled high-density lipoprotein nanoparticles","volume":"56","author":"P\u00e9rez-Medina","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0225","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1038\/ncomms11221","article-title":"Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0230","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.nano.2015.01.003","article-title":"Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties","volume":"11","author":"Nordin","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1609629113","article-title":"Immune cell screening of a nanoparticle library improves atherosclerosis therapy","volume":"113","author":"Tang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0240","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/mp100309y","article-title":"Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis","volume":"7","author":"Lobatto","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0245","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.nano.2015.02.021","article-title":"Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration","volume":"11","author":"van der Valk","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0250","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcmg.2016.01.020","article-title":"In vivo PET imaging of hdl in multiple atherosclerosis models","volume":"9","author":"P\u00e9rez-Medina","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bc500517k","article-title":"HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages","volume":"26","author":"Sanchez-Gaytan","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0260","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejpb.2015.06.010","article-title":"HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth","volume":"94","author":"Naksuriya","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201600160","article-title":"Physico-chemical strategies to enhance stability and drug retention of polymeric micelles for tumor-targeted drug delivery","volume":"17","author":"Shi","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0270","article-title":"Strategies for improving the payload of small molecular drugs in polymeric micelles","author":"Zhang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0275","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/nn4048205","article-title":"Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes","volume":"8","author":"Quan","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.addr.2009.11.029","article-title":"Micelles based on HPMA copolymers?","volume":"62","author":"Talelli","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0285","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphar.2015.00247","article-title":"HDL as a drug and nucleic acid delivery vehicle","volume":"6","author":"Lacko","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0290","article-title":"Real-time monitoring of nanoparticle formation by FRET imaging","author":"Sanchez-Gaytan","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0295","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2217\/nnm.14.170","article-title":"Fluorophore labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging","volume":"10","author":"Shi","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0300","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/bc200288d","article-title":"Modular strategy for the construction of Radiometalated antibodies for positron emission tomography based on inverse electron demand Diels\u2013Alder click chemistry","volume":"22","author":"Zeglis","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0305","doi-asserted-by":"crossref","first-page":"10907","DOI":"10.1021\/cr500314d","article-title":"Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects","volume":"115","author":"Kunjachan","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0310","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpharm.2013.02.046","article-title":"SMART drug delivery systems: back to the future vs. clinical reality","volume":"454","author":"Lammers","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0315","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0320","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14064","article-title":"Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease","volume":"8","author":"Keliher","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/mrm.10360","article-title":"Characterization of aortic root atherosclerosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation","volume":"49","author":"Itskovich","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0330","series-title":"Cardiovasc. Dis. Vol. 2 Mol. Med","first-page":"83","article-title":"Quantitative assay for mouse atherosclerosis in the aortic root","author":"Baglione","year":"2006"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0335","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/ATVBAHA.111.237693","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0340","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","article-title":"Therapeutic siRNA silencing in inflammatory monocytes in mice","volume":"29","author":"Leuschner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0345","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","article-title":"Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells","volume":"37","author":"Zigmond","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.ki.5000053","article-title":"Progression of kidney disease: blocking leukocyte recruitment with chemokine receptor CCR1 antagonists","volume":"69","author":"Anders","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0355","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000128849.12617.f4","article-title":"Atherosclerosis in the apolipoprotein E\u2013deficient mouse","volume":"24","author":"Meir","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00281-013-0409-1","article-title":"From proliferation to proliferation: monocyte lineage comes full circle","volume":"36","author":"Swirski","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0365","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-016-0535-8","article-title":"Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression","volume":"111","author":"Lindau","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0370","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd1088","article-title":"The dawning era of polymer therapeutics","volume":"2","author":"Duncan","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0375","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0142-9612(89)90075-6","article-title":"Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro","volume":"10","author":"Rihova","year":"1989","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.07.013_bb0380","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1389201033489711","article-title":"Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers","volume":"4","author":"R\u00edhov\u00e1","year":"2003","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0385","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.addr.2009.12.005","article-title":"Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities?","volume":"62","author":"Duncan","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.07.013_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591730723X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591730723X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T11:40:36Z","timestamp":1656243636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591730723X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":78,"alternative-id":["S016836591730723X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}